N,N-Dipropyltryptamine Psychedelic Therapy

N,N-Dipropyltryptamine and LSD are addressed as substances within the context of clinical psychedelic therapy. Kenneth Pew, a 39-year-old terminal cancer patient, undergoes professionally monitored psychedelic sessions to assist in coping with physical pain and end-of-life anxiety. The therapeutic approach emphasizes the need for extensive patient preparation and a secure, supportive setting to guide individuals through the drug-induced states. Careful control and medical supervision emerge as fundamental pillars for mitigating potential adverse effects such as distress or violent reactions. Such sessions are intended to provide patients with an opportunity to express and confront fears, ultimately aiming to enhance the quality of life despite the prognosis.